Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham S Cooke

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
Eclinicalmedicine|May 11, 2026
Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trialHugo C Turner, Sayara Ahmed, Huyen Anh Nguyen, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Wellcome Open Research|September 22, 2020
The direct-medical costs associated with interferon-based treatment for Hepatitis C in VietnamHuyen Anh Nguyen, Graham S Cooke, Jeremy N Day, et al.
American Journal of Public Health|March 9, 2023
Design and Implementation of a National SARS-CoV-2 Monitoring Program in England: REACT-1 StudyPaul Elliott, Matthew Whitaker, David Tang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2022
Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow ImmunoassayChristina J Atchison, Maya Moshe, Jonathan C Brown, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Communications Medicine|July 11, 2022
Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodiesNathan C K Wong, Sepehr Meshkinfamfard, Valérian Turbé, et al.
Med (New York, N.Y.)|February 7, 2022
Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19Ravi Mehta, Elena Chekmeneva, Heather Jackson, et al.
Clinical Liver Disease|June 5, 2023
Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failureBarnaby Flower, Phuong Nguyen Thi Ngoc, Leanne McCabe, et al.
The Lancet. Infectious Diseases|December 1, 2024
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patientsHelen Callaby, Janie Olver, Kirsty Emery, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
Eclinicalmedicine|May 11, 2026
Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trialHugo C Turner, Sayara Ahmed, Huyen Anh Nguyen, et al.
The Lancet. Rheumatology|January 22, 2024
Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODYFiona A Pearce, Sean H Lim, Mary Bythell, et al.
Wellcome Open Research|September 22, 2020
The direct-medical costs associated with interferon-based treatment for Hepatitis C in VietnamHuyen Anh Nguyen, Graham S Cooke, Jeremy N Day, et al.
American Journal of Public Health|March 9, 2023
Design and Implementation of a National SARS-CoV-2 Monitoring Program in England: REACT-1 StudyPaul Elliott, Matthew Whitaker, David Tang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2022
Validity of Self-testing at Home With Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Detection by Lateral Flow ImmunoassayChristina J Atchison, Maya Moshe, Jonathan C Brown, et al.
Lancet (London, England)|January 25, 2025
Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY studyLisa Mumford, Rachel Hogg, Adam Taylor, et al.
Communications Medicine|July 11, 2022
Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodiesNathan C K Wong, Sepehr Meshkinfamfard, Valérian Turbé, et al.
Med (New York, N.Y.)|February 7, 2022
Antiviral metabolite 3'-deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19Ravi Mehta, Elena Chekmeneva, Heather Jackson, et al.
Clinical Liver Disease|June 5, 2023
Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failureBarnaby Flower, Phuong Nguyen Thi Ngoc, Leanne McCabe, et al.
The Lancet. Infectious Diseases|December 1, 2024
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patientsHelen Callaby, Janie Olver, Kirsty Emery, et al.
Pageof 17